expenses down Baht 36.4 million Y-O-Y mainly from the reduction of revenue -related variable costs, travelling and marketing – related expenses due to the impact of Covid -19 pandemic; - and a higher CIT

in goods deliveries for part of the above-mentioned projects to Q4/2019; - SG&A including Interest expenses were down Baht 6.9 million Y-O-Y on lower variable expenses relating to performance; - CIT

, transactions that are subject to variable fee rates shall be based on volume they made; and the intermediaries that enter into the same type business activities shall pay the same rates of fee; or fees shall

is selected to include in Thailand Sustainability Investment (THSI) among other 65 listed companies by the Stock of Exchange of Thailand (SET). This selection does not only reflect how the company

income totaling Baht 47.79 million was mainly affected by the discontinue of profits from sale of investment assets which had occurred only in the year 2018. Nevertheless, Asia Medical & Agricultural

Ended Dec 31, 2019 operating results that posted a difference greater than 20% To Director and Manager the Stocks Exchange of Thailand Currently, only Thailand Public Company Limited is a manufacturer and

of Appointing Independence Director of Derivatives Intermediary before this Notification TRANSLATED VERSION As of June 3, 2014 Readers should be aware that only the original Thai text has legal force

before this Notification TRANSLATED VERSION As of June 3, 2014 Readers should be aware that only the original Thai text has legal force and that this English translation is strictly for reference.ะกาศตาม 2

Microsoft Word - SorkhorNor 37-2550 final (UNOFFICIAL TRANSLATION) Readers should be aware that only the original Thai text has legal force and that this English translation is strictly for reference

Translation (UNOFFICIAL TRANSLATION) PAGE 2 Readers should be aware that only the original Thai text has legal force and that this English translation is strictly for reference. The SEC, Thailand